have also been demonstrated to promote a variety of monocyte and macrophage responses, including enhancement of migration or chemotaxis (14) (15) (16) , induction of lysosomal enzyme secretion (17) , and polarization (18) . We assume that these cellular responses, like those of the neutrophil, result from binding of C5a to specific cellular receptors. To confirm this hypothesis, we have characterized the binding interactions of radiolabeled human C5a with both adherent cells isolated from the peritoneal cavity of C3H/HeJ mice and the murine macrophage cell line designated P388D1.
Materials and Methods
Preparation of Human CSa and CSa Derivatives. Human C5a anaphylatoxin was purified to homogeneity from zymosan-activated human serum containing 1 M e-aminocaproic acid by the methods of Fernandez and Hugli (19) . The naturally occurring derivative C5aa~,~, was isolated from zymosan-activated human serum in the absence of the carboxypeptidase inhibitor (1) . An additional C5a derivative, termed C5a-(1-69), which consists of the N-terminal 69 residues of C5a, was prepared by carboxypeptidase Y digestion of C5aa~ ~u, as previously described (10) .
Human C5a was radiolabeled with Na 125I (Amersham Corp., Arlington Heights, IL) by a solid phase lactoperoxidase-glucose oxidase method (Enzymobead; Bio-Rad Laboratories, Richmond, CA) using conditions recommended by the manufacturer (Bio-Rad Technical Bulletin 1060). Free 1251 and damaged radiolabeled C5a were separated from antigenically reactive 12SI-C5a by immunoaffinity chromatography on a 1.0-ml column of rabbit anti-C5a IgG-Sepharose 4B. Native 125I-C5a was eluted with 0.2 M glycine-HC1, pH 2.3, and immediately neutralized with 1 M K2HPO4. The specific activity of such preparations was typically 20-40 /zCi//zg. Radiolabeled C5a was judged to have retained its native character by the fact that it was >90% bound by an excess of rabbit anti-human C5a immunoglobulin in solid phase radioimmunoassays (20) and >85% bound by human neutrophils.
Mice. Male mice (C3H/St), 8-12 wk of age, were obtained from the mouse breeding colony at Scripps Clinic and Research Foundation. Mice were maintained on Wayne Lab-Blox F6 pellets (Allied Mills, Inc., Chicago, IL) and chlorinated water acidified with HCI to a pH of 3.0 (21) .
Cell Isolation and Culture. Resident peritoneal cells were obtained by peritoneal lavage with 3.0 ml of a sterile balanced salt solution (BSS) supplemented with 100 U of penicillin G/ml, 100 #g of streptomycin/ml, and 0.5 U (USP) of sodium heparin/ml. Thioglycollate-induced peritoneal cells were similarly obtained 6 d after intraperitoneal injection of thioglycollate. Before use, all peritoneal cells were irradiated with 1,000 rad from a Gamma cell 40 small animal irradiator (Atomic Energy of Canada Ltd., Ottawa, Canada). This irradiator uses a cesium 137 source emitting a central dose-rate of 100 rad/min. Differential cell counts were performed on each cell preparation before performing 125I-C5a binding assays. Typically, 10-30% of resident peritoneal cells were esterase positive, whereas 90-95% of the thioglycollateinduced cells were esterase positive. The number of peritoneal cells used was adjusted for percent cells of monocytoid histology. Cells of this morphological type were radiation-resistant, esterase-positive, adherent antigen-presenting cells. For these reasons they will be referred to as "maerophages."
Murine spleen cell suspensions were prepared as previously described (22) . These cells were depleted of adherent cells by passage over columns of . The lymphocyte population recovered from this procedure typically contained <0.12% esterase-positive cells.
In selected experiments, murine resident peritoneal cells were depleted of Ia-positive cells by treatment with monoclonal anti-Ia K antibodies and complement. Monoclonal anti-Ia K was obtained as a culture supernatant from hybridoma 10-2.16 developed in the laboratory of Dr. L. A. Herzenberg at Stanford University. This antibody is of the 72b subclass. It reacts with Ia specificities of the r, f, and s haplotype in addition to Ia K (24) . Treatment with this supernatant followed by addition of guinea pig complement (Colorado Serum Co., Denver, GO) typically killed ~ 18% of resident peritoneal ceils from C3H/St mice.
The cell lines P388 and P388D1 were kindly provided by the Salk Institute for Biological Studies, La Jolla, CA. P388 cells were cultured in Dulbecco's minimum essential medium (high glucose) supplemented with 50 gM 2-mercaptoethanol, 20 mM Hepes, and 10% heat-inactivated fetal calf serum (FCS). P388D1 cells were cultured in RPMI 1640 supplemented with 5% heatinactivated FCS. Additionally, both types of media were supplemented with glutamine, nonessential amino acids, and antibiotics as described for lymphocyte culture (22) . Human peripheral blood neutrophils were prepared from the heparin-anticoagulated venous blood of healthy male volunteers according to standard methods (25) .
l~I-C5a Cell Binding Assays. Cellular binding of a25I-C5a was assessed by previously published methods (10) . Briefly, 125I-C5a was diluted to an appropriate concentration (0.3-60 nM) in Hanks' balanced salt solution containing 0.5% gelatin (HBSS-G) (Microbiological Associates , Walkersville, MD) and incubated with test cells suspended in HBSS-G. Incubation volumes were routinely 100 #1, and binding reactions were carried out in 1.5-ml conical polypropylene mierofuge tubes (Cole Scientific, Calabasas, CA). To terminate the binding reaction, cells were rapidly pelleted by centrifugation at 11,000 g in a Beckman Microfuge B (Beckman Instruments, Inc., Palo Alto, CA) for 30 s. To determine the amount of cell-bound 125I-C5a, one-half the supernatant solution plus tile material remaining in the microfuge tube (residual supernatant and cell pellet) was counted as a paired sample in a Packard Autogamma Spectrometer (Packard Instrument Co., Downers Grove, IL) with 70% efficiency. The amount of cell-bound 125I-C5a was then calculated from the formula given previously (10) . Nonspecific binding of x2~I-C5a to polypropylene tubes was <1% when assays were performed in this manner.
Identification of l~I-C5a Degradation Products. Molecular sieve ehromatography was utilized to identify 125I-C5a degradation products released by murine macrophages upon prolonged incubation at 37°C. For these experiments, peritoneal cells from C3H/HeJ mice (1 × 107/ml in HBSS-G) were incubated with 1 nM 125I-C5a for 20 min at 37°C to permit ligand binding. After removal of unbound 12~I-C5a by washing, the cells were resuspended in HBSS-G and incubated for an additional 2 h at 37°C. Cells were then pelleted by centrifugation, and 100 gl of the incubation supernatant was removed and chromatographed on a 0.7 × 30-cm column of Bio Gel P-100 (100-200 mesh; Bio-Rad Laboratories). The column was eluted at a flow rate of 4.65 ml/h with phosphate-buffered saline, pH 7.4, and 0.3-ml fractions were collected. Radioactive content of individual fractions was assessed by counting gamma emissions as above.
Results

Time Course and Temperature Dependence of 12SI-C5a
Binding. The time course of 125I-labeled human C5a binding to resident murine peritoneal macrophages at both 4°C and 37°C is shown in Fig. 1 . Cellular uptake of the ligand was equally rapid at both temperatures. At 4°C, binding was maximal after 45 min, and steady-state binding was demonstrable with incubation for up to 120 min. When binding was carried out at 37°C, maximal cellular uptake of 125I-C5a was observed after 20 min incubation. With more prolonged incubation at this temperature, the amount of cellbound radioisotope steadily decreased, being barely detectable after 120 min of incubation. This type of kinetic profile, i.e., ligand uptake followed by cellular release of radioisotope, has been consistently observed when a25I-C5a is incubated with neutrophils at 37°C (11, 12) or when target cells bind and subsequently degrade bioaetive polypeptides (reviewed in 26).
To determine if murine macrophages degrade cell-associated 125I-C5a, cells that had been incubated with lzsI-C5a for 20 min at 37°C were washed and incubated in the absence of C5a for an additional 2 h at 37°C. When supernatants from these cultures were subjected to gel filtration chromatography on Bio Gel P-100 (Fig. 2) only ~ 15% of the released radioisotope eluted as intact a25I-C5a. The vast majority of the radioactive material eluted between 11 and 13.5 ml, a position whose elution volume was consistent with that of mono-iodotyrosine or small peptides. Further analysis of this low molecular weight fraction demonstrated that it did not bind to ELUTION VOLUME (ml)
Fzo. 2. Bio Gel P-I00 column chromatography of radiolabel released from murine (C3H/HeJ) resident peritoneal macrophages. Cells (1 × 107/ml in HBSS-G) were incubated with 1 nM 125I-C5a for 20 min at 37°C, washed to remove unbound ligand, resuspended in HBSS-G at a density of 1 X 107/ml, and incubated for an additional 2 h at 37°C. Cells were pelleted by centrifugation, and a 100-#1 aliquot of the incubation supernatant was chromatographed on a 0.7 × 30-cm column of P-100 resin. Two separate experiments gave identical results.
either human neutrophils or to freshly-prepared murine peritoneal macrophages. Additionally, it was not bound by an excess of rabbit anti-human C5a immunoglobulin.
Concentration Dependence of z~I-labeled Human C5a
Binding to Murine Macrophages. Incubation of murine resident peritoneal macrophages with varying concentrations of 125I-C5a for 20 min at 37°C demonstrated a saturable binding interaction, with a nonspeeific binding component at elevated ligand concentrations (Fig. 3) . A Scatchard plot of these data (Fig. 4) uptake of 125I-C5a at a concentration of 20 ng/ml (2.5 nM), implying that the C5a receptors of each cell type exhibited the same apparent Ka. On the other hand, resident macrophages displayed ~2 × 105 receptors/cell, whereas the thioglycollateinduced macrophages possessed only 4-5 × 104 C5a receptors per cell. Splenic lymphocytes, rendered free of adherent cells by passage through Sephadex G-10, did not bind 125I-C5a. Thus, the C5a receptor is expressed by macrophages, but is not found in significant numbers on murine splenic lymphocytes. Additional studies of this type have also been conducted to determine if C5a receptors exist on murine macrophage cell lines. The results of these investigations are summarized in Table I . Our findings indicate that the cell line P388D1, but not its parent P388, expressed C5a receptors. The apparent Ka of the C5a receptor expressed by P388D1 was 2 nM, and 8-10 × 104 C5a binding sites were detectable on each cell.
We have also assessed the binding of t25I-C5a to unseparated and Ia-depleted murine cells. To accomplish this, Ia-positive cells were removed from the normal peritoneal macrophage population by lysis with specific anti-Ia antiserum and complement. Evaluation of the binding of 1 nM 12gI-C5a for 20 min at 37°C by normal and Ia-depleted cells demonstrated that the normal mixed cell population bound 36.3 + 1.8 (mean --SD) fmol of 125I-C5a, whereas the macrophage population depleted of Ia-positive cells bound 47.6 ± 1.2 (mean -t-SD) fmol of z2~I-C5a. This difference was judged to be statistically significant (P < 0.001).
Discussion
Our current investigations clearly demonstrate that murine macrophages, like human peripheral blood neutrophils (10), possess a specific receptor for the complement-derived C5a anaphylatoxin. The characteristics of the murine macrophage C5a receptor are quantitatively similar to those of the human neutrophil (10), i.e., the apparent Ka is estimated to be 2-3 nM, and each cell bears ~200,000 C5a receptors. Radiolabeled human C5a binds rapidly to macrophages obtained from the peritoneal cavity of C3H mice. The rate of association of the ligand with these cells appears to be equally rapid whether binding takes place at 4°C or 37°C, implying receptormediated uptake of the biologically active factor. When incubations are conducted entirely at 4°C, steady-state binding is obtained. In contrast, when binding interactions take place at 37°C, uptake and time-dependent release of radiolabel is observed, suggesting that a temperature-dependent process(es), such as internalization, is re-sponsible for these phenomena (12) . Therefore, murine peritoneal macrophages appear to behave like human neutrophils, being capable of degrading cell-bound 125I-C5a.
Although we have not specifically attempted to prove that murine macrophages internalize 125I-C5a like human neutrophils, 1 we have clearly demonstrated that the macrophage is capable of degrading C5a to its constituent amino acids and/or small peptides. Supernatants recovered from cells incubated with 125I-C5a for 2 h at 37°C were chromatographically resolved on a molecular sieve resin and shown to consist predominantly of low molecular weight radiolabeled fragments. The fact that these low molecular weight species were not bound by either freshly-prepared human neutrophils, murine macrophages, or anti-C5a immunoglobulin indicated that they were neither biologically nor antigenically reactive. Thus, macrophages, like neutrophils, are able to degrade and inactivate cell-bound C5a. Based on our own observations with neutrophils 1 and the study of polypeptide hormones conducted by many other investigators (26) , it is likely that macrophage internalization of 125I-C5a precedes the degradative-inactivation process(es).
Resident macrophages isolated from the peritoneal cavity of C3H mice demonstrate a single class of high affinity C5a receptors. Scatchard analysis of t25I-C5a concentration-dependent binding data indicates that these receptors display an average Ka of 3 nM, and that there are ~2 × 105 receptors on each cell. These values correlate closely with those observed for human neutrophils (10) . Some low affÉnity or nonspecific binding interactions are also demonstrated by this type of analysis. The fact that a 100-fold molar excess of unlabeled C5a completely blocks binding of 125I-C5a suggests that these low affinity interactions may represent a second population of low affinity receptors rather than simply nonspecific binding.
The C5a receptors of murine macrophages, like their neutrophil counterparts, exhibit a high degree of ligand specificity (6, 10) . Unlabeled human C5a and its derivatives C5ades ~g and C5a-(1-69) are all capable of inhibiting 125I-C5a binding to the macrophage receptor. The relative affinities of each unlabeled ligand, i.e., C5a>C5ade~g>C5a- , are comparable to those demonstrated with human neutrophils (6, 10) . These findings imply that the macrophage C5a receptor may be structurally analogous to the human neutrophil C5a receptor. If this is true, then the macrophage C5a receptor may consist of both a ligand binding domain that interacts with the N-terminal region of C5a and an activation binding domain that specifically interacts with the C-terminal portion of C5a (6) .
The macrophage C5a receptor is found not only on murine resident peritoneal macrophages, but is also demonstrable on thioglycollate-induced peritoneal cells and cultured cell lines. In all instances, the apparent Kd of the receptor is nearly identical, being I-3 nM. Adherent cells from different sources appear to differ predominantly with regard to the number of receptors expressed. For example, resident peritoneal macrophages have four to five times as many receptors as their thioglycollate-induced counterparts and approximately twice as many receptors as the P388D~ cell line. Interestingly, the cell line P388, which is the parent of P388Da, fails to express a detectable number of C5a receptors. The fact that C5a receptor density may vary widely, whereas the apparent Ka remains constant, is substantiated by the observation that human alveolar macrophages, guinea pig alveolar macrophages, and human peripheral blood monocytes display C5a receptors whose apparent Kd values are 1-3 nM. However, each of these cell types express differing numbers of receptors, i.e., human alveolar macrophages, ~3 × 105; guinea pig alveolar macrophages, ~0.5 × 105; and human monocytes, ~ 1 × 105 (unpublished observations).
We have observed that lysis of Ia-positive cells with specific anti-Ia antisera and complement actually increases subsequent binding of 125I-C5a to the viable peritoneal cells remaining in culture. The magnitude of the enhancement of 12~I-C5a specific uptake is consistent with the fact that such lytic procedures removed the 10-20% of Ia-positive cells, which would be normally expected in the resident peritoneal macrophage population, and implies that Ia-negative cells are largely responsible for the observed binding of C5a. This conclusion is substantiated by the finding that the Ianegative cell line P388D1 also binds 125I-C5a.
Although other investigators have demonstrated that C5a or a similar polypeptide in activated serum is capable of promoting macrophage cellular responses (14-18), we have chosen to focus on a new biological activity ascribable to C5a. As we have demonstrated, C5a promotes macrophage-dependent enhancement of the immune response. 3 The close correspondence between the observed dose-response profile for this phenomenon and that of 125I-C5a binding to macrophages implies that the binding of C5a to its macrophage receptor eventuates in a significant biological response and further confirms the specific nature of the macrophage C5a receptor. Summary Human C5a anaphylatoxin is known to be a potent mediator of the acute inflammatory response. It serves to trigger a wide variety of neutrophil responses after binding to a specific cellular receptor. We have now demonstrated that this bioactive glycopolypeptide is also bound to a specific receptor found on murine resident peritoneal macrophages, thioglycollate-induced exudate macrophages, and the murine cell line P388Dx. The apparent Kd of the C5a receptor for each cell type is ~2 nM, but each cell expresses a differing number of C5a receptors. Resident macrophages appear to have an average of 2 × 105 binding sites per cell, whereas thioglycollateinduced cells have only 4-5 × 104 binding sites. The continuous cell line P388D1 is intermediate between these two cell types, exhibiting 8-10 × 104 C5a receptors per cell. Neither murine lymphocytes nor the parent cell line P388 displays a measurable number of C5a receptors. Macrophage receptor-C5a binding interactions are followed by cellular uptake and degradation of a25I-C5a, much as is observed with neutrophils.
As demonstrated in another paper, binding of C5a to macrophages results in augmentation of the primary humoral immune response as well as enhancement of mixed lymphocyte reactions. 3 These observations suggest that C5a should not only be considered as an acute inflammatory mediator but as an immunopotentiating modulator as well, thus serving as a critical link between complement activation and subsequent immune responses.
